ACADIA Pharmaceuticals, Inc. (ACAD) to Present at Upcoming Investor Conferences  
8/29/2012 9:53:04 AM

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the following investor conferences: